Endoglin Antikörper (AA 43-287)
Kurzübersicht für Endoglin Antikörper (AA 43-287) (ABIN5027184)
Target
Alle Endoglin (ENG) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 43-287
-
Aufreinigung
- Protein G Chromatography
-
Immunogen
- A partial length recombinant Endoglin protein (amino acids 43-287) was used as the immunogen for this antibody.
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
- WB: 2-4 μg/mL
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 0.5 mg/mL
-
Buffer
- PBS containing 0.05 % BSA, PH 7.4
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody at 4°C, stable for 6 months. For long-term storage, store at -20°C. Avoid repeated freeze and thaw cycles.
-
-
- Endoglin (ENG)
-
Andere Bezeichnung
- Endoglin
-
Hintergrund
- ENG (Endoglin) is an integral membrane glycoprotein that serves as a co receptor for members of the transforming growth factor-beta superfamily of proteins. It is a type I membrane glycoprotein expressed as a disulfide-linked homodimer on human vascular endothelial cells and is implicated in a dominant vascular dysplasia known as hereditary hemorrhagic telangiectasia as well as in preeclampsia. Endoglin suppresses human prostate cancer (PCa) cell invasion. It has been identified as a candidate tumor-suppressor gene in esophageal squamous cell carcinoma (ESCC).
-
Molekulargewicht
- 70 kDa
-
Gen-ID
- 2022
-
UniProt
- P17813
Target
-